Suppr超能文献

低聚果糖和动物双歧杆菌联合作用对肥胖大鼠肠道菌群和血糖的影响。

Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats.

机构信息

Faculty of Kinesiology, University of Calgary, Alberta, Canada.

出版信息

Obesity (Silver Spring). 2014 Mar;22(3):763-71. doi: 10.1002/oby.20632. Epub 2013 Oct 17.

Abstract

OBJECTIVE

Prebiotics and probiotics may be able to modify an obesity-associated gut microbiota. The aim of this study was to examine the individual and combined effects of the prebiotic oligofructose (OFS) and the probiotic Bifidobacterium animalis subsp. lactis BB-12 (BB-12) on gut microbiota and host metabolism in obese rats.

METHODS

Adult male, diet-induced obese Sprague Dawley rats were randomized to: (1) Control (C); (2) 10% OFS; (3) BB-12; (4) OFS + BB-12 for 8 weeks (n = 9-10 rats/group). Body composition, glycemia, gut permeability, satiety hormones, cytokines, and gut microbiota were examined.

RESULTS

Prebiotic, but not probiotic reduced energy intake, weight gain, and fat mass (P < 0.01). OFS, BB-12, and the combined OFS + BB-12 improved glycemia (P < 0.05). Individually, OFS and BB-12 reduced insulin levels (P < 0.05). Portal GLP-1 was increased with OFS, whereas probiotic increased GLP-2 (P < 0.05). There was a marked increase in bifidobacteria and lactobacilli (P < 0.01) with OFS that was not observed with probiotic alone.

CONCLUSIONS

The impact of prebiotic intake on body composition and gut microbiota was of greater magnitude than the probiotic BB-12. Despite this, an improvement in glucose AUC with both prebiotic or probiotic demonstrates the beneficial role of each of these "biotic" agents in glycemic control.

摘要

目的

益生菌和益生元可能能够改变与肥胖相关的肠道微生物群。本研究旨在研究低聚果糖(OFS)和双歧杆菌乳亚种 BB-12(BB-12)这两种益生元单独和联合对肥胖大鼠肠道微生物群和宿主代谢的影响。

方法

成年雄性,饮食诱导肥胖的 Sprague Dawley 大鼠被随机分为:(1)对照组(C);(2)10% OFS;(3)BB-12;(4)OFS + BB-12 共 8 周(n = 9-10 只/组)。检测了身体成分、血糖、肠道通透性、饱腹感激素、细胞因子和肠道微生物群。

结果

益生元而非益生菌可降低能量摄入、体重增加和脂肪量(P < 0.01)。OFS、BB-12 和 OFS + BB-12 联合使用均可改善血糖(P < 0.05)。单独使用 OFS 和 BB-12 均可降低胰岛素水平(P < 0.05)。OFS 可增加门静脉 GLP-1,而益生菌可增加 GLP-2(P < 0.05)。OFS 可显著增加双歧杆菌和乳酸杆菌(P < 0.01),而单独使用益生菌则没有观察到这种情况。

结论

益生元摄入对身体成分和肠道微生物群的影响大于益生菌 BB-12。尽管如此,益生元和益生菌均能改善 AUC 血糖,这表明这两种“生物制剂”在血糖控制方面均有益处。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验